{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:14:17Z","timestamp":1790082857545,"version":"4.0.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21bk0104108"],"award-info":[{"award-number":["JP21bk0104108"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We previously demonstrated that CD34\u2009+\u2009cell transplantation in animals healed intractable fractures via osteogenesis and vasculogenesis; we also demonstrated the safety and efficacy of this cell therapy in an earlier phase I\/II clinical trial conducted on seven patients with fracture nonunion. Herein, we present the results of a phase III clinical trial conducted to confirm the results of the previous phase studies using a larger cohort of patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>CD34\u2009+\u2009cells were mobilized via administration of granulocyte colony-stimulating factor, harvested using leukapheresis, and isolated using magnetic cell sorting. Autologous CD34\u2009+\u2009cells were transplanted in 15 patients with tibia nonunion and 10 patients with femur nonunion, who were followed up for 52\u00a0weeks post transplantation. The main outcome was a reduction in time to heal the tibia in nonunion patients compared with that in historical control patients. We calculated the required number of patients as 15 based on the results of the phase I\/II study. An independent data monitoring committee performed the radiographic assessments. Adverse events and medical device failures were recorded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All fractures healed during the study period. The time to radiological fracture healing was 2.8 times shorter in patients with CD34\u2009+\u2009cell transplantation than in the historical control group (hazard ratio: 2.81 and 95% confidence interval 1.16\u20136.85); moreover, no safety concerns were observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings strongly suggest that autologous CD34\u2009+\u2009cell transplantation is a novel treatment option for fracture nonunion.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>UMIN-CTR, UMIN000022814. Registered on 22 June 2016.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-023-03088-y","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T21:01:46Z","timestamp":1696539706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Phase III clinical trial of autologous CD34\u2009+\u2009cell transplantation to accelerate fracture nonunion repair"],"prefix":"10.1186","volume":"21","author":[{"given":"Ryosuke","family":"Kuroda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0951-5812","authenticated-orcid":false,"given":"Takahiro","family":"Niikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Oe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Mifune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimikazu","family":"Yakushijin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Kagimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiko","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"3088_CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00003086-200402000-00003","volume":"419","author":"EC Rodriguez-Merchan","year":"2004","unstructured":"Rodriguez-Merchan EC, Forriol F. Nonunion: general principles and experimental data. Clin Orthop Relat Res. 2004;419:4\u201312.","journal-title":"Clin Orthop Relat Res"},{"issue":"Suppl 2","key":"3088_CR2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.injury.2014.04.002","volume":"45","author":"DJ Hak","year":"2014","unstructured":"Hak DJ, Fitzpatrick D, Bishop JA, Marsh JL, Tilp S, Schnettler R, et al. Delayed union and nonunions: epidemiology, clinical issues, and financial aspects. Injury. 2014;45(Suppl 2):S3\u20137.","journal-title":"Injury"},{"key":"3088_CR3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00776-013-0472-4","volume":"19","author":"T Niikura","year":"2014","unstructured":"Niikura T, Lee SY, Sakai Y, Nishida K, Kuroda R, Kurosaka M. Causative factors of fracture nonunion: the proportions of mechanical, biological, patient-dependent, and patient-independent factors. J Orthop Sci. 2014;19:120\u20134.","journal-title":"J Orthop Sci"},{"key":"3088_CR4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00003086-199405000-00029","volume":"302","author":"K Dickson","year":"1994","unstructured":"Dickson K, Katzman S, Delgado E, Contreras D. Delayed unions and nonunions of open tibial fractures. Correlation with arteriography results. Clin Orthop Relat Res. 1994;302:189\u201393.","journal-title":"Clin Orthop Relat Res"},{"key":"3088_CR5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/jor.20264","volume":"25","author":"C Lu","year":"2007","unstructured":"Lu C, Miclau T, Hu D, Marcucio RS. Ischemia leads to delayed union during fracture healing: a mouse model. J Orthop Res. 2007;25:51\u201361.","journal-title":"J Orthop Res"},{"issue":"Suppl 1","key":"3088_CR6","first-page":"S151","volume":"83\u2013A(2)","author":"GE Friedlaender","year":"2001","unstructured":"Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001;83\u2013A(2)(Suppl 1):S151\u20138.","journal-title":"J Bone Joint Surg Am"},{"issue":"Suppl 3","key":"3088_CR7","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0020-1383(09)70012-9","volume":"40","author":"G Zimmermann","year":"2009","unstructured":"Zimmermann G, Wagner C, Schmeckenbecher K, Wentzensen A, Moghaddam A. Treatment of tibial shaft non-unions: bone morphogenetic proteins versus autologous bone graft. Injury. 2009;40(Suppl 3):S50\u20133.","journal-title":"Injury"},{"issue":"Suppl 8","key":"3088_CR8","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0020-1383(15)30056-5","volume":"46","author":"GM Calori","year":"2015","unstructured":"Calori GM, Colombo M, Bucci M, Mazza EL, Fadigati P, Mazzola S. Clinical effectiveness of Osigraft in long-bones non-unions. Injury. 2015;46(Suppl 8):S55\u201364.","journal-title":"Injury"},{"key":"3088_CR9","doi-asserted-by":"crossref","first-page":"e877","DOI":"10.3928\/01477447-20111021-09","volume":"34","author":"MA Tressler","year":"2011","unstructured":"Tressler MA, Richards JE, Sofianos D, Comrie FK, Kregor PJ, Obremskey WT. Bone morphogenetic protein-2 compared to autologous iliac crest bone graft in the treatment of long bone nonunion. Orthopedics. 2011;34:e877\u201384.","journal-title":"Orthopedics"},{"key":"3088_CR10","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.3928\/01477447-20140528-51","volume":"37","author":"R Takemoto","year":"2014","unstructured":"Takemoto R, Forman J, Taormina DP, Egol KA. No advantage to rhBMP-2 in addition to autogenous graft for fracture nonunion. Orthopedics. 2014;37:e525\u201330.","journal-title":"Orthopedics"},{"key":"3088_CR11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.injury.2015.11.038","volume":"47","author":"C von R\u00fcden","year":"2016","unstructured":"von R\u00fcden C, Morgenstern M, Hierholzer C, Hackl S, Gradinger FL, Woltmann A, et al. The missing effect of human recombinant bone morphogenetic proteins BMP-2 and BMP-7 in surgical treatment of aseptic forearm nonunion. Injury. 2016;47:919\u201324.","journal-title":"Injury"},{"key":"3088_CR12","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s00264-016-3262-8","volume":"40","author":"C von R\u00fcden","year":"2016","unstructured":"von R\u00fcden C, Morgenstern M, Friederichs J, Augat P, Hackl S, Woltmann A, et al. Comparative study suggests that human bone morphogenetic proteins have no influence on the outcome of operative treatment of aseptic clavicle non-unions. Int Orthop. 2016;40:2339\u201345.","journal-title":"Int Orthop"},{"key":"3088_CR13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12891-017-1704-0","volume":"18","author":"S Hackl","year":"2017","unstructured":"Hackl S, Hierholzer C, Friederichs J, Woltmann A, B\u00fchren V, von R\u00fcden C. Long-term outcome following additional rhBMP-7 application in revision surgery of aseptic humeral, femoral, and tibial shaft nonunion. BMC Musculoskelet Disord. 2017;18:342.","journal-title":"BMC Musculoskelet Disord"},{"issue":"Suppl 4","key":"3088_CR14","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.injury.2005.10.010","volume":"36","author":"R Dimitriou","year":"2005","unstructured":"Dimitriou R, Dahabreh Z, Katsoulis E, Matthews SJ, Branfoot T, Giannoudis PV. Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury. 2005;36(Suppl 4):S51\u20139.","journal-title":"Injury"},{"issue":"Suppl 3","key":"3088_CR15","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/S0020-1383(09)70013-0","volume":"40","author":"NK Kanakaris","year":"2009","unstructured":"Kanakaris NK, Lasanianos N, Calori GM, Verdonk R, Blokhuis TJ, Cherubino P, et al. Application of bone morphogenetic proteins to femoral non-unions: a 4-year multicentre experience. Injury. 2009;40(Suppl 3):S54\u201361.","journal-title":"Injury"},{"key":"3088_CR16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00402-009-0982-x","volume":"130","author":"A Moghaddam","year":"2010","unstructured":"Moghaddam A, Elleser C, Biglari B, Wentzensen A, Zimmermann G. Clinical application of BMP 7 in long bone non-unions. Arch Orthop Trauma Surg. 2010;130:71\u20136.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"7","key":"3088_CR17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1302\/0301-620X.97B7.35089","volume":"97-B","author":"M Papanagiotou","year":"2015","unstructured":"Papanagiotou M, Dailiana ZH, Karachalios T, Varitimidis S, Vlychou M, Hantes M, et al. RhBMP-7 for the treatment of nonunion of fractures of long bones. Bone Joint J. 2015;97-B(7):997\u20131003.","journal-title":"Bone Joint J"},{"key":"3088_CR18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.injury.2015.11.035","volume":"47","author":"Z Morison","year":"2016","unstructured":"Morison Z, Vicente M, Schemitsch EH, McKee MD. The treatment of atrophic, recalcitrant long-bone nonunion in the upper extremity with human recombinant bone morphogenetic protein-7 (rhBMP-7) and plate fixation: a retrospective review. Injury. 2016;47:356\u201363.","journal-title":"Injury"},{"issue":"Suppl 3","key":"3088_CR19","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.injury.2005.07.035","volume":"36","author":"PV Giannoudis","year":"2005","unstructured":"Giannoudis PV, Tzioupis C. Clinical applications of BMP-7: the UK perspective. Injury. 2005;36(Suppl 3):S47\u201350.","journal-title":"Injury"},{"key":"3088_CR20","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.3390\/jcm10194597","volume":"10","author":"T Fuchs","year":"2021","unstructured":"Fuchs T, Stolberg-Stolberg J, Michel PA, Garcia P, Amler S, W\u00e4hnert D, et al. Effect of bone morphogenetic protein-2 in the treatment of long bone non-unions. J Clin Med. 2021;10:4597.","journal-title":"J Clin Med"},{"key":"3088_CR21","first-page":"e1049","volume":"37","author":"JD Conway","year":"2014","unstructured":"Conway JD, Shabtai L, Bauernschub A, Specht SC. BMP-7 versus BMP-2 for the treatment of long bone nonunion. Orthopedics. 2014;37:e1049\u201357.","journal-title":"Orthopedics"},{"key":"3088_CR22","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.otsr.2018.08.008","volume":"104","author":"P Haubruck","year":"2018","unstructured":"Haubruck P, Tanner MC, Vlachopoulos W, Hagelskamp S, Miska M, Ober J, et al. Comparison of the clinical effectiveness of bone morphogenic protein (BMP) \u22122 and \u22127 in the adjunct treatment of lower limb nonunions. Orthop Traumatol Surg Res. 2018;104:1241\u20138.","journal-title":"Orthop Traumatol Surg Res"},{"key":"3088_CR23","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00402-014-2014-8","volume":"134","author":"PF Hannemann","year":"2014","unstructured":"Hannemann PF, Mommers EHH, Schots JPM, Brink PRG, Poeze M. The effects of low-intensity pulsed ultrasound and pulsed electromagnetic fields bone growth stimulation in acute fractures: a systematic review and meta-analysis of randomized controlled trials. Arch Orthop Trauma Surg. 2014;134:1093\u2013106.","journal-title":"Arch Orthop Trauma Surg"},{"key":"3088_CR24","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","volume":"275","author":"T Asahara","year":"1997","unstructured":"Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964\u20137.","journal-title":"Science"},{"key":"3088_CR25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.RES.85.3.221","volume":"85","author":"T Asahara","year":"1999","unstructured":"Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221\u20138.","journal-title":"Circ Res"},{"key":"3088_CR26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/7434","volume":"5","author":"T Takahashi","year":"1999","unstructured":"Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5:434\u20138.","journal-title":"Nat Med"},{"key":"3088_CR27","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1161\/CIRCULATIONAHA.106.687376","volume":"115","author":"DW Losordo","year":"2007","unstructured":"Losordo DW, Schatz RA, White CJ, Udelson JE, Veereshwarayya V, Durgin M, et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I\/IIa double-blind, randomized controlled trial. Circulation. 2007;115:3165\u201372.","journal-title":"Circulation"},{"key":"3088_CR28","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/stem.207","volume":"27","author":"A Kawamoto","year":"2009","unstructured":"Kawamoto A, Katayama M, Handa N, Kinoshita M, Takano H, Horii M, et al. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I\/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells. 2009;27:2857\u201364.","journal-title":"Stem Cells"},{"key":"3088_CR29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1253\/circj.CJ-13-0864","volume":"78","author":"Y Fujita","year":"2014","unstructured":"Fujita Y, Kinoshita M, Furukawa Y, Nagano T, Hashimoto H, Hirami Y, et al. Phase II clinical trial of CD34+ cell therapy to explore endpoint selection and timing in patients with critical limb ischemia. Circ J. 2014;78:490\u2013501.","journal-title":"Circ J"},{"key":"3088_CR30","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/sctm.18-0104","volume":"7","author":"T Ohtake","year":"2018","unstructured":"Ohtake T, Mochida Y, Ishioka K, Oka M, Maesato K, Moriya H, et al. Autologous granulocyte colony-stimulating factor-mobilized peripheral blood CD34 positive cell transplantation for hemodialysis patients with critical limb ischemia: a prospective Phase II clinical trial. Stem Cells Transl Med. 2018;7:774\u201382.","journal-title":"Stem Cells Transl Med"},{"key":"3088_CR31","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1172\/JCI114852","volume":"86","author":"MW Long","year":"1990","unstructured":"Long MW, Williams JL, Mann KG. Expression of human bone-related proteins in the hematopoietic microenvironment. J Clin Invest. 1990;86:1387\u201395.","journal-title":"J Clin Invest"},{"key":"3088_CR32","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/stem.150368","volume":"15","author":"JL Chen","year":"1997","unstructured":"Chen JL, Hunt P, McElvain M, Black T, Kaufman S, Choi ES. Osteoblast precursor cells are found in CD34+ cells from human bone marrow. Stem Cells. 1997;15:368\u201377.","journal-title":"Stem Cells"},{"key":"3088_CR33","doi-asserted-by":"crossref","first-page":"11761","DOI":"10.1073\/pnas.0404626101","volume":"101","author":"M Dominici","year":"2004","unstructured":"Dominici M, Pritchard C, Garlits JE, Hofmann TJ, Persons DA, Horwitz EM. Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci USA. 2004;101:11761\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3088_CR34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.orthres.2003.08.010","volume":"22","author":"JL Ford","year":"2004","unstructured":"Ford JL, Robinson DE, Scammell BE. Endochondral ossification in fracture callus during long bone repair: the localisation of \u201ccavity-lining cells\u201d within the cartilage. J Orthop Res. 2004;22:368\u201375.","journal-title":"J Orthop Res"},{"key":"3088_CR35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1634\/stemcells.2004-0330","volume":"23","author":"T Tondreau","year":"2005","unstructured":"Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M, et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells. 2005;23:1105\u201312.","journal-title":"Stem Cells"},{"key":"3088_CR36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jor.20228","volume":"25","author":"AJ Laing","year":"2007","unstructured":"Laing AJ, Dillon JP, Condon ET, Street JT, Wang JH, McGuinness AJ, et al. Mobilization of endothelial precursor cells: systemic vascular response to musculoskeletal trauma. J Orthop Res. 2007;25:44\u201350.","journal-title":"J Orthop Res"},{"key":"3088_CR37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/jcp.21309","volume":"215","author":"T Matsumoto","year":"2008","unstructured":"Matsumoto T, Mifune Y, Kawamoto A, Kuroda R, Shoji T, Iwasaki H, et al. Fracture induced mobilization and incorporation of bone marrow-derived endothelial progenitor cells for bone healing. J Cell Physiol. 2008;215:234\u201342.","journal-title":"J Cell Physiol"},{"key":"3088_CR38","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.2353\/ajpath.2006.060064","volume":"169","author":"T Matsumoto","year":"2006","unstructured":"Matsumoto T, Kawamoto A, Kuroda R, Ishikawa M, Mifune Y, Iwasaki H, et al. Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Am J Pathol. 2006;169:1440\u201357.","journal-title":"Am J Pathol"},{"key":"3088_CR39","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1634\/stemcells.2007-0820","volume":"26","author":"Y Mifune","year":"2008","unstructured":"Mifune Y, Matsumoto T, Kawamoto A, Kuroda R, Shoji T, Iwasaki H, et al. Local delivery of granulocyte colony stimulating factor-mobilized CD34-positive progenitor cells using bioscaffold for modality of unhealing bone fracture. Stem Cells. 2008;26:1395\u2013405.","journal-title":"Stem Cells"},{"key":"3088_CR40","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3727\/096368914X681586","volume":"24","author":"T Fukui","year":"2015","unstructured":"Fukui T, Mifune Y, Matsumoto T, Shoji T, Kawakami Y, Kawamoto A, et al. Superior potential of CD34-positive cells compared to total mononuclear cells for healing of nonunion following bone fracture. Cell Transplant. 2015;24:1379\u201393.","journal-title":"Cell Transplant"},{"key":"3088_CR41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5966\/sctm.2013-0106","volume":"3","author":"R Kuroda","year":"2014","unstructured":"Kuroda R, Matsumoto T, Niikura T, Kawakami Y, Fukui T, Lee SY, et al. Local transplantation of granulocyte colony stimulating factor-mobilized CD34+ cells for patients with femoral and tibial nonunion: pilot clinical trial. Stem Cells Transl Med. 2014;3:128\u201334.","journal-title":"Stem Cells Transl Med"},{"key":"3088_CR42","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1016\/0168-8227(94)90246-1","volume":"24 Suppl","author":"M Fukuda","year":"1994","unstructured":"Fukuda M. Classification and treatment of diabetic retinopathy. Diabetes Res Clin Pract. 1994;24 Suppl:S171\u20136.","journal-title":"Diabetes Res Clin Pract"},{"issue":"Suppl 1","key":"3088_CR43","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/BOT.0000000000001063","volume":"32","author":"EG Meinberg","year":"2018","unstructured":"Meinberg EG, Agel J, Roberts CS, Karam MD, Kellam JF. Fracture and dislocation classification compendium-2018. J Orthop Trauma. 2018;32(Suppl 1):S1\u2013170.","journal-title":"J Orthop Trauma"},{"key":"3088_CR44","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.injury.2010.11.048","volume":"42","author":"C Vannabouathong","year":"2011","unstructured":"Vannabouathong C, Sprague S, Bhandari M. Guidelines for fracture healing assessments in clinical trials. Part I: definitions and endpoint committees. Injury. 2011;42:314\u20136.","journal-title":"Injury"},{"issue":"Suppl 1","key":"3088_CR45","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1097\/BOT.0b013e3181ca3fd1","volume":"24","author":"BW Kooistra","year":"2010","unstructured":"Kooistra BW, Dijkman BG, Busse JW, Sprague S, Schemitsch EH, Bhandari M. The radiographic union scale in tibial fractures: reliability and validity. J Orthop Trauma. 2010;24(Suppl 1):S81\u20136.","journal-title":"J Orthop Trauma"},{"key":"3088_CR46","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00256-013-1605-8","volume":"42","author":"MM Chiavaras","year":"2013","unstructured":"Chiavaras MM, Bains S, Choudur H, Parasu N, Jacobson J, Ayeni O, et al. The radiographic union score for hip (RUSH): the use of a checklist to evaluate hip fracture healing improves agreement between radiologists and orthopedic surgeons. Skelet Radiol. 2013;42:1079\u201388.","journal-title":"Skelet Radiol"},{"key":"3088_CR47","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","volume":"305","author":"JE Brazier","year":"1992","unstructured":"Brazier JE, Harper R, Jones NM, O\u2019Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305:160\u20134.","journal-title":"BMJ"},{"key":"3088_CR48","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2106\/00004623-200405000-00003","volume":"86","author":"NA Johanson","year":"2004","unstructured":"Johanson NA, Liang MH, Daltroy L, Rudicel S, Richmond J. American Academy of Orthopaedic Surgeons lower limb outcomes assessment instruments. Reliability, validity, and sensitivity to change. J Bone Joint Surg Am. 2004;86:902\u20139.","journal-title":"J Bone Joint Surg Am"},{"key":"3088_CR49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10156-010-0183-0","volume":"17","author":"A Watanabe","year":"2011","unstructured":"Japanese Society of Chemotherapy, Antimicrobial Agents Safety Evaluation Standards Committee, Watanabe A, Tokue Y, Aoki N, Matsumoto T, et al. Criteria for safety evaluation of antimicrobial agents. J Infect Chemother. 2011;17:139\u201347.","journal-title":"J Infect Chemother"},{"key":"3088_CR50","first-page":"1430","volume":"87","author":"P Hernigou","year":"2005","unstructured":"Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am. 2005;87:1430\u20137.","journal-title":"J Bone Joint Surg Am"},{"key":"3088_CR51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/230949901302100116","volume":"21","author":"AK Singh","year":"2013","unstructured":"Singh AK, Shetty S, Saraswathy JJ, Sinha A. Percutaneous autologous bone marrow injections for delayed or non-union of bones. J Orthop Surg (Hong Kong). 2013;21:60\u20134.","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"3088_CR52","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00590-013-1369-9","volume":"24","author":"H Sugaya","year":"2014","unstructured":"Sugaya H, Mishima H, Aoto K, Li M, Shimizu Y, Yoshioka T, et al. Percutaneous autologous concentrated bone marrow grafting in the treatment for nonunion. Eur J Orthop Surg Traumatol. 2014;24:671\u20138.","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"3088_CR53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1302\/2046-3758.57.2000587","volume":"5","author":"HD Ismail","year":"2016","unstructured":"Ismail HD, Phedy P, Kholinne E, Djaja YP, Kusnadi Y, Merlina M, et al. Mesenchymal stem cell implantation in atrophic nonunion of the long bones: a translational study. Bone Joint Res. 2016;5:287\u201393.","journal-title":"Bone Joint Res"},{"issue":"Suppl 1","key":"3088_CR54","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.injury.2020.02.070","volume":"51","author":"E G\u00f3mez-Barrena","year":"2020","unstructured":"G\u00f3mez-Barrena E, Padilla-Eguiluz N, Rosset P, Gebhard F, Hernigou P, Baldini N, et al. Early efficacy evaluation of mesenchymal stromal cells (MSC) combined to biomaterials to treat long bone non-unions. Injury. 2020;51(Suppl 1):S63\u201373.","journal-title":"Injury"},{"key":"3088_CR55","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/0963689718818096","volume":"28","author":"X Wang","year":"2019","unstructured":"Wang X, Chu W, Zhuang Y, Shi D, Tao H, Jin C, et al. Bone mesenchymal stem cell-enriched \u03b2-tricalcium phosphate scaffold processed by the screen-enrich-combine circulating system promotes regeneration of diaphyseal bone non-union. Cell Transplant. 2019;28:212\u201323.","journal-title":"Cell Transplant"},{"key":"3088_CR56","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.biomaterials.2018.03.033","volume":"196","author":"E G\u00f3mez-Barrena","year":"2019","unstructured":"G\u00f3mez-Barrena E, Rosset P, Gebhard F, Hernigou P, Baldini N, Rouard H, et al. Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial. Biomaterials. 2019;196:100\u20138.","journal-title":"Biomaterials"},{"key":"3088_CR57","doi-asserted-by":"crossref","first-page":"e2220","DOI":"10.1097\/MD.0000000000002220","volume":"94","author":"D Dufrane","year":"2015","unstructured":"Dufrane D, Docquier PL, Delloye C, Poirel HA, Andr\u00e9 W, Aouassar N. Scaffold-free three-dimensional graft from autologous adipose-derived stem cells for large bone defect reconstruction: clinical proof of concept. Medicine. 2015;94:e2220.","journal-title":"Medicine"},{"key":"3088_CR58","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/S0020-1383(15)30055-3","volume":"46 Suppl 8","author":"PV Giannoudis","year":"2015","unstructured":"Giannoudis PV, Gudipati S, Harwood P, Kanakaris NK. Long bone non-unions treated with the diamond concept: a case series of 64 patients. Injury. 2015;46 Suppl 8:S48\u201354.","journal-title":"Injury"},{"key":"3088_CR59","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1089\/ten.tea.2009.0268","volume":"16","author":"K Ishida","year":"2010","unstructured":"Ishida K, Matsumoto T, Sasaki K, Mifune Y, Tei K, Kubo S, et al. Bone regeneration properties of granulocyte colony-stimulating factor via neovascularization and osteogenesis. Tissue Eng Part A. 2010;16:3271\u201384.","journal-title":"Tissue Eng Part A"},{"key":"3088_CR60","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clinbiomech.2018.07.010","volume":"58","author":"D Moukoko","year":"2018","unstructured":"Moukoko D, Pourquier D, Genovesio C, Thezenas S, Chabrand P, Roffino S, et al. Granulocyte-colony stimulating factor enhances bone fracture healing. Clin Biomech (Bristol Avon). 2018;58:62\u20138.","journal-title":"Clin Biomech (Bristol Avon)"},{"key":"3088_CR61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.amsu.2020.12.005","volume":"61","author":"A Kurniawan","year":"2021","unstructured":"Kurniawan A, Kodrat E, Gani YI. Effectiveness of granulocyte colony stimulating factor to enhance healing on delayed union fracture model Sprague-Dawley rat. Ann Med Surg (Lond). 2021;61:54\u201360.","journal-title":"Ann Med Surg (Lond)"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-03088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-023-03088-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-03088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:25:34Z","timestamp":1700490334000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-023-03088-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3088"],"URL":"https:\/\/doi.org\/10.1186\/s12916-023-03088-y","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,5]]},"assertion":[{"value":"18 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol conformed to the Declaration of Helsinki and was approved by the institutional review boards of Kobe University Hospital, Teikyo University Hospital, Iwate Medical University Hospital, Kagawa University Hospital, Hyogo Medical University Hospital, Kobe City Medical Center General Hospital, and Institute of Biomedical Research and Innovation Hospital. A clinical trial notification was submitted to the Pharmaceuticals and Medical Devices Agency (PMDA), Japan, and the study was initiated after obtaining the PMDA\u2019s permission. Furthermore, ethical approval was obtained from all seven participating hospitals. All patients provided written informed consent to participate in this trial. This trial has been registered at UMIN-CTR under UMIN000022814. There are no restrictions on study-related materials.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"386"}}